Dermatology life quality index: Time to move forward

Journal of Investigative Dermatology

Volumn 132, Issue 1, 2012, Pages 11-13

  Nijsten, Tamar ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGY LIFE QUALITY INDEX; HUMAN; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUALITY OF LIFE INDEX; QUESTIONNAIRE; REVIEW; STANDARD;

EID: 84856105664     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.354     Document Type: Note

References (13)

1. Basra M, Zammit AM, Salek S et al. (2011) Application of Rasch analysis to Psoriasis Family Index (PFI)-a novel psoriasis-specific quality of life instrument for family members and partners of psoriasis patients. J Invest Dermatol 131:S49
2. Both H, Essink-Bot ML, Busschbach J et al. (2007) Critical review of generic and dermatologyspecific health-related quality of life instruments. J Invest Dermatol 127:2726-39 (Pubitemid 350134835)
3. De Korte J, Mombers FM, Sprangers MA et al. (2002) The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review. Arch Dermatol 138:1221-7 (Pubitemid 35025697)
4. Finlay AY, Khan GK (1994) Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 19:210-6 (Pubitemid 24194579)
5. McHorney CA (1997) Generic health measurement: past accomplishments and a measurement paradigm for the 21st century. Ann Intern Med 127:743-50 (Pubitemid 27446559)
6. McKenna SP, Meads DM, Doward LC (2004) Scaling properties of the Dermatology Life Quality Index (DLQI). Value Health 7:750-1
7. Muldoon MF, Barger SD, Flory JD et al. (1998) What are quality of life measurements measuring? BMJ 316:542-5 (Pubitemid 28120965)
8. Nijsten T, Meads DM, McKenna SP (2006a) Dimensionality of the Dermatology Life Quality Index (DLQI): a commentary. Acta Derm Venereol 86:284-5 (Pubitemid 43875235)
9. Nijsten TE, Sampogna F, Chren MM et al. (2006b) Testing and reducing Skindex-29 using Rasch analysis: Skindex-17. J Invest Dermatol 126:1244-50 (Pubitemid 43997903)
10. Nijsten T, Meads DM, de Korte J et al. (2007) Cross-cultural inequivalence of dermatologyspecific health-related quality of life instruments in psoriasis patients. J Invest Dermatol 127:2315-22 (Pubitemid 47619752)
11. Tennant A, McKenna SP, Hagell P (2004) Application of Rasch analysis in the development and application of quality of life instruments. Value Health1:S22-6 (Pubitemid 39390826)
12. Twiss J, Meads DM, Preston EP et al. (2012) Can we rely on the Dermatology Life Quality Index as a measure of the impact of psoriasis or atopic dermatitis? J Invest Dermatol 132:76-84
13. Whalley D, McKenna SP, Dewar AL et al. (2004) A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD). Br J Dermatol 150:274-83. (Pubitemid 38352465)